See analyst estimates and all valuation multiples for Drug Delivery Systems
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $17.3B | 6.4x | 26.8x | |
| $14.5B | 790.6x | -13.0x | |
| $4.8B | 3.5x | 13.9x | |
| $3.8B | n/a | n/a | |
| $3.3B | 12.3x | 29.8x | |
| $3.0B | 20.3x | -55.8x | |
| $2.8B | 2.3x | 8.3x | |
| $2.5B | n/a | n/a | |
| $1.6B | 4.6x | n/a | |
| $1.1B | 217.1x | -8.4x | |
| $1.0B | 29.2x | -136.3x | |
| $889M | 28.0x | -3.7x | |
| $859M | 15.7x | -3.2x | |
| $684M | 8.4x | n/a | |
| $521M | 14.1x | 54.4x | |
| $386M | 31.7x | 1188.1x | |
| $363M | n/a | -13.8x | |
| $255M | 5.7x | -14.0x | |
| $236M | n/a | n/a | |
| $235M | 2.8x | 10.0x | |
| $167M | 6.6x | n/a | |
| $147M | 4.5x | -1.0x | |
| $134M | 25.9x | n/a | |
| $134M | 18.1x | -35.1x | |
| $130M | 9.3x | -9.3x | |
| $112M | n/a | n/a | |
| $104M | 4.6x | -80.4x | |
| $66.2M | n/a | n/a | |
| $60.7M | 1444.1x | n/a | |
| $57.8M | 8.4x | -14.5x | |
| $52.3M | 14.2x | -2.3x | |
| $50.6M | n/a | n/a | |
| $47.0M | 17.4x | n/a | |
| $41.2M | n/a | n/a | |
| $38.0M | n/a | -2.7x | |
| $33.0M | 34.9x | n/a | |
| $25.0M | 20.5x | n/a | |
| $19.1M | 254.9x | n/a | |
| $12.1M | 16.6x | n/a | |
| $11.1M | n/a | n/a | |
| $2.0M | n/a | n/a | |
| -$5.1M | n/a | n/a |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Drug Delivery Systems